Stenting for dysphagia due to recurrent malignant tumors

Introduction. Stenting for recurrent esophageal and gastric cancer to resolve dysphagia is a relatively rare intervention. Scientific publications devoted to this issue are very rare.

The objective was to analyze the effectiveness, complications and life expectancy after esophageal stenting in patients with recurrent esophageal and gastric cancer after surgery.

Methods and materials. Self-expanding metal esophageal stents were installed under videoendoscopic control in 45 patients with dysphagia due to esophageal and gastric cancer, for the period from 2013 to 2023, at the Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after M. Z. Sigal. RESULTS. There were no complications directly during the intervention. Dysphagia indicators decreased by an average of 2 points. In the early and late periods, complications arose in 16 cases (36 %), including stent migration, continued tumor tissue growth, granulation stricture, stent deformation, and pain syndrome. Ineffectiveness of stenting due to the impossibility of endoscopic resolution of the complications that arose was noted in three cases (19 % of the total number of complications). The average survival time was 128 days.

Conclusion. Stenting in this category of patients is a fairly effective way to resolve dysphagia in a short time, but complications are quite common and not all of them can be resolved by endoscopic methods.

1. Hulscher J. B. F., Sandic J. W., Tijssen J. G. P et al. The recurrence pattern of esophageal carcinoma after transhiatal resection. J. Am Coll Surg. 2000;191:143–148. https://doi.org/10.1016/S1072-7515(00)00349-5.

2. Kato H., Tachimori Y., Watanabe H. et al. Anastomotic recurrence of esophageal squamous cell carcinoma after transthoracic esophagectomy. Eur J. Surg. 1998;164:759–764.

3. Parshad R., Singh R. K., Kumar A. et al. Adenocarcinoma of distal esophagus and gastroesophageal junction: Long-term results of surgical treatment in a north indian center. World J. Surg. 1999;23:277–283. https://doi.org/10.1007/PL00013179.

4. Sanz L., Gonzalez J. J., Miyar A. et al. Pattern of recurrence after esophageal resection for cancer. Hepatogastroenterology. 1999;46:2393–2397.

5. Hoksch B., Müller J. M. Surgical manage ment of locoregional recurrence of gastric carcinoma. Zentralbl Chir. 1999;124:1087–1090.

6. Shiraishi N., Inomata M., Osawa N. et al. Early and late recurrence after gastrectomy for gastric carcinoma.Univariate analysis. Cancer. 2000;89:255–261. https://doi.org/10.1002/1097-0142(20000715)89:2<255::AID-CNCR8>3.0.CO;2-N.

7. Böhner H., Zimmer T. H., Hopfenmüller W. et al. Detection and prognosis of recurrent gastric cancer – is routine follow-up after gastrectomy worthwhile? Hepatogastroenterol. 2000;47:1489–1494.

8. Schumacher I. K., Hunsicker A., Petermann J., Lorenz D. Magenkarzinomchirurgie – Bewährtes und Kontroverses. Chirurg. 1999;70:1447–1453. https://doi.org/10.1007/s001040050085.

9. Yoo C. H., Noh S. H., Shin D. W. et al. Recurrence following curative resection for gastric carcinoma. Br J. Surg. 2000;87:236–242. https://doi.org/10.1046/j.1365-2168.2000.01360.x.

10. Kaibara N., Sumi K., Yonekawa M. et al. Does extensive dissection of lymph nodes improve the results of surgical treatment of gastric cancer? Am J. Surg. 1990;159:218–221. https://doi.org/10.1016/S0002-9610(05)80265-X.

11. Telford J. J., Carr-Locke D. L., Baron T. H. et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc. 2004;60:916‒20. https://doi.org/10.1016/S0016-5107(04)02228-X.

12. Dormann A., Meisner S., Verin N. et al. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy. 2004;36:543‒50. https://doi.org/10.1055/s-2004-814434.

13. Thompson A. M., Rapson T., Gilbert F. J. et al. Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patients. Surg Endosc. 2004;18:1257‒62. https://doi.org/10.1007/s00464-003-9256-9.

14. Kim G. H., Kang D. H., Lee D. H. et al. Which types of stent, uncovered or covered, should be used in gastric outlet obstructions? Scand J Gastroenterol 2004;39:1010‒4.

15. Maetani I., Inoue H., Sato M. et al. Peroral insertion techniques of selfexpanding metal stents for malignant gastric outlet and duodenal stenoses. Gastrointest Endosc. 1996;44:468‒71. https://doi.org/10.1080/00365520410003146.

16. Nevitt A. W., Vida F., Kozarek R. A. et al. Expandable metallic prostheses for malignant obstruction of gastric outlet and proximal small bowel. Gastrointest Endosc. 1998;47:271‒6. https://doi.org/10.1016/S0016-5107(98)70326-8.

17. Bethge N., Breiktuetz C., Vakil N. Metal stents for the palliation of inoperable upper gastrointestinal stenoses. Am J. Gastroenterol 1998;93:643‒5. https://doi.org/10.1111/j.1572-0241.1998.182_b.x.

18. Adler D. G., Baron T. H. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J. Gastroenterol. 2002;97:72‒8. https://doi.org/10.1111/j.1572-0241.2002.05423.x.

19. Jeong J. Y., Han J. K., Kim A. Y. et al. Fluoroscopically guided placement of a covered self-expandable metallic stent for malignant antroduodenal obstructions: preliminary results in 18 patients. AJR Am J. Roentgenol. 2002;178:847‒852. https://doi.org/10.2214/ajr.178.4.1780847.

20. Bal M. S., Bodal V. K., Kaur J. et al. Patterns of Cancer: A Study of 500 Punjabi Patients. Asian Pac J. Cancer Prev. 2015;16(12):5107–10. https://doi.org/10.7314/apjcp.2015.16.12.5107.

21. Alsop B. R., Sharma P. Esophageal cancer. Gastroenterol Clin North Am. 2016;45(3):399–412. https://doi.org/10.1016/j.gtc.2016.04.001.

22. Wong S. K., Chiu P. W., Leung S. F. et al. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: A case-control study. Ann Surg Oncol. 2008;15:576–582. https://doi.org/10.1245/s10434-007-9679-y.

23. Adler D. G., Baron T. H. Endoscopic palliation of malignant dysphagia. Mayo Clin Proc. 2001;76:731–738. https://doi.org/10.4065/76.7.731.

24. Loser C., Wolters S., Folsch U. R. Enteral long-term nutrition via percutaneous endoscopic gastrostomy (PEG) in 210 patients: a fouryear prospective study. Dig Dis Sci. 1998;43:2549–2557. https://doi.org/10.1023/A:1026615106348.

25. Ljungdahl M. Complication rate lower after percutaneous endoscopic gastrostomy than after surgical gastrostomy: a prospective, randomized trial. Surg Endosc. 2006;20(8):1248‒51. https://doi.org/10.1007/s00464-005-0757-6.

26. Bergstrom L. R., Larson De, Zinsmeister A. R. et al. Utilization and outcomes of surgical gastrostomies and jejunostomies in an era of percutaneous endoscopic gastrostomy: a population-based study. Mayo Clm Proc. 1995;70(9):829‒36.

27. Mamontov A. S., Sokolov V. V., Vereshchagin V. G. Treatment strategy for unresectable esophageal cancer with grade II–IV dysphagia: bypass surgery, gastrostomy or endoprosthetics? Palliative Medicine and Rehabilitation. 2003;(2):88–89. (In Russ.).

28. Patton J. T., Carter R. Endoscopic stenting for recurrent malignant gastric outlet obstruction. Br J. Surg. 1997;84:865‒6.

29. Wayman J., Bliss R., Richardson D. L. et al. Self-expanding metal stents in the palliation of small bowel stenosis secondary to recurrent gastric cancer. Gastrointest Endosc. 1998;47:286‒90.

30. Jeong J. Y., Kim Y. J., Han J. K. et al. Palliation of anastomotic obstructions in recurrent gastric carcinoma with the use of covered metallic stents: clinical results in 25 patients. Surgery. 2004;135:171‒7.

31. Cheung H. Y., Chung S. C. Covered metal stent for tumor obstruction of efferent loop recurrence after gastrectomy. Surg Endosc. 1997;11:936‒8.

32. Sherwood P., Duggan A., Shek F. et al. Esophagojejunal stenting for recurrent gastric carcinoma. Gastrointest Endosc. 1998;47:192‒4.

33. Lee J. M., Han Y. M., Lee S. Y. et al. Palliation of postoperative gastrointestinal anastomotic malignant strictures with flexible covered metallic stents: preliminary results. Cardiovasc Intervent Radiol. 2001;24:25‒30.

34. Kim H. J., Park J.Y., Bang S. et al. Self-expandable metal stents for recurrent malignant obstruction after gastric surgery. Hepatogastroenterology. 2009;56(91‒92):914‒7.

35. Cho Y. K., Kim S. W., Nam K. W. et al. Clinical outcomes of self-expandable metal stents in palliation of malignant anastomotic strictures caused by recurrent gastric cancer. World J. Gastroenterol. 2009;28;15(28):3523‒7.

36. Verschuur E. M., Steyerberg E. W., Kuipers E. J., Siersema P. D. Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer. Gastrointest. Endoscopy. 2007;65(4):592–601. https://doi.org/10.1016/j.gie.2006.12.018.

37. Song G. A., Kang D. H., Kim T. O. et al. Endoscopic stenting in patients with recurrent malignant obstruction after gastric surgery: uncovered versus simultaneously deployed uncovered and covered (double) selfexpandable metal stents. Gastrointest Endosc. 2007;65(6):782‒7. https://doi.org/10.1016/j.gie.2006.08.030.

38. Sharma P., Kozarek R. Practice Parameters Committee of American College of Gastroenterology Role of esophageal stents in benign and malignant diseases. Am. J. Gastroenterol. 2010;105:258–273. https://doi.org/10.1038/ajg.2009.684.

39. Siersema P. D., Hop W. C., van Blankenstein M. et al. A comparison of 3 types of covered metal stents for the palliation of patients caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest. Endosc. 2001;54:145–153. https://doi.org/10.1067/mge.2001.116879.

40. Wlodarczyk J., Kuzdzal J. Stenting as a palliative method in the management of advanced squamous cell carcinoma of the oesophagus and gastro-oesophageal junction. Wideochirurgia i inne techniki maloinwazyjne. 2016;11(1):1–8. https://doi.org/10.5114/wiitm.2016.58979.

41. Bor R., Fabian A., Balint A. et al. Endoscopic management of complications of self-expandable metal stents for treatment of malignant esophageal stenosis and tracheoesophageal fistulas. TheraP.Adv. Gastroenterol. 2017;10(8):599–607. https://doi.org/10.1177/1756283X17718408.

42. Yang J., Siddiqui A. A., Kowalski T. E. et al. Esophageal stent fixation with endoscopic suturing device improves clinical outcomes and reduces complications in patients with locally advanced esophageal cancer prior to neoadjuvant therapy: a large multicenter experience. Surg. Endosc. 2017;31:1414–1419. https://doi.org/10.1007/s00464-016-5131-3.

43. Na H. K., Song H. Y., Kim J. H. et al. How to design the optimal selfexpandable oesophageal metallic stents: 22 years of experience in 645 patients with malignant strictures. Eur. Radiol. 2013;23:786–796. https://doi.org/10.1007/s00330-012-2661-5.

44. Seven G., Irani S., Ross A. S. et al. Partially versus fully covered selfexpanding metal stents for benign and malignant esophageal conditions: a single center experience. Surg. Endosc. 2013;27:2185–2192. https://doi.org/10.1007/s00464-012-2738-x.

45. Van Boeckel P. G., Repici A., Vleggaar F. P. et al. A new metal stent with a controlled-release system for palliation of malignant dysphagia: a prospective, multicenter study. Gastrointest. Endosc. 2010;71:455–460. https://doi.org/10.1016/j.gie.2009.09.046.

46. Choi S. J., Kim J. H., Choi J. W. et al. Fully covered, retrievable selfexpanding metal stents (Niti-S) in palliation of malignant dysphagia: long-term results of a prospective study. Scand. J. Gastroenterol. 2011;46:875–880. https://doi.org/10.3109/00365521.2011.571706.

47. Reijm A. N., Didden P., Bruno M. J., Spaander M. C. Early pain detection and management after esophageal metal stent placement in incurable cancer patients: A prospective observational cohort study. Endosc. Int. Open. 2016;4(8):E890–E894. https://doi.org/10.1055/s-0042-111202.

48. Uesato M., Akutsu Y., Murakami K., Muto Y. Comparison of efficacy of self-expandable metallic stent placement in the unresectable esophageal cancer patients. Hindawi Gastroenterol. Res. Pract. 2017;7:2560510. https://doi.org/10.1155/2017/2560510.

49. Ferreira F., Bastos P., Ribeiro A. et al. A compara tive study between fluoroscopic and endoscopic guidance in palliative esophageal stent placement. Dis. Esophagus. 2012;25:608–613. https://doi.org/10.1111/j.1442-2050.2011.01288.x.

50. Qiu G., Tao Y., Du X. et al. The impact of prior ra diotherapy on fatal complications after self-expandable me tallic stents (SEMS) for malignant dysphagia due to esopha geal carcinoma. Dis. Esophagus. 2013;26:175–181. https://doi.org/10.1111/j.1442-2050.2012.01348.x